Mircette: Effective Low-Dose Oral Contraceptive with Minimal Side Effects
| Product dosage: 15mcg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 56 | $1.15 | $64.50 (0%) | 🛒 Add to cart |
| 84 | $0.94 | $96.75 $79.12 (18%) | 🛒 Add to cart |
| 112 | $0.83 | $129.00 $92.88 (28%) | 🛒 Add to cart |
| 168 | $0.72 | $193.50 $121.26 (37%) | 🛒 Add to cart |
| 224 | $0.67
Best per pill | $258.00 $149.64 (42%) | 🛒 Add to cart |
Synonyms | |||
Mircette is a combination oral contraceptive pill prescribed for the prevention of pregnancy. It utilizes a unique dosing regimen that combines ethinyl estradiol and desogestrel to provide reliable contraception with a lower hormonal load. This formulation is designed to offer high efficacy while potentially minimizing common estrogen-related side effects, making it a suitable option for many patients seeking a reversible birth control method. Healthcare providers often consider Mircette for its balance of effectiveness and tolerability profile.
Features
- Contains ethinyl estradiol (20 mcg) and desogestrel (0.15 mg)
- 21 active tablets followed by 2 inert tablets and 5 very low-dose estrogen tablets
- Monophasic formulation providing consistent hormone levels
- Packaged in a 28-day blister pack for ease of use
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides highly effective pregnancy prevention when taken correctly
- May result in lighter, more regular menstrual periods
- Potential reduction in estrogen-related side effects due to low hormone content
- Can improve acne in some patients
- Offers flexibility with a simple missed dose protocol
- May decrease risk of iron deficiency anemia through reduced menstrual flow
Common use
Mircette is primarily prescribed for contraception in women of reproductive age. It may also be used off-label for menstrual cycle regulation in patients with irregular periods. Some practitioners prescribe combination oral contraceptives like Mircette for the management of moderate acne in women who also desire contraception. The medication is not indicated for post-coital emergency contraception.
Dosage and direction
Take one tablet daily at approximately the same time each day, following the directional arrows on the blister pack. Begin with the first active tablet (yellow) on the first Sunday after menstruation begins or on the first day of menstruation. Continue taking one tablet daily for 28 days: 21 active tablets, then 2 inert tablets (green), followed by 5 very low-dose estrogen tablets (yellow). Begin a new pack the day after finishing the previous pack, regardless of menstrual flow. Use a backup contraceptive method for the first 7 days of the first cycle.
Precautions
Do not smoke while taking Mircette, especially if over age 35, as this significantly increases risk of serious cardiovascular events. This medication does not protect against HIV infection or other sexually transmitted diseases. Regular follow-up with a healthcare provider is recommended, including annual blood pressure checks and periodic health assessments. Notify your physician of any planned surgeries or prolonged immobilization. Monitor for possible vision changes or eye discomfort, particularly if wearing contact lenses.
Contraindications
Mircette is contraindicated in patients with: current or history of thrombophlebitis or thromboembolic disorders; cerebrovascular or coronary artery disease; known or suspected carcinoma of the breast or estrogen-dependent neoplasia; undiagnosed abnormal genital bleeding; known or suspected pregnancy; hepatic dysfunction or disease; and hypersensitivity to any component of this product. Additional contraindications include headaches with focal neurological symptoms and diabetes with vascular involvement.
Possible side effects
Common side effects may include nausea, vomiting, headache, breast tenderness, irregular bleeding, weight changes, and mood changes. Serious but rare adverse effects include thrombophlebitis, pulmonary embolism, myocardial infarction, cerebral hemorrhage, cerebral thrombosis, hypertension, gallbladder disease, and hepatic adenomas. Any sudden onset of severe headache, chest pain, leg pain, shortness of breath, or visual changes should prompt immediate medical attention.
Drug interaction
Mircette may interact with: anticonvulsants (carbamazepine, phenytoin, phenobarbital); antibiotics (rifampin, griseofulvin); certain antifungals; HIV protease inhibitors; St. John’s wort; and other medications that induce hepatic enzymes. These interactions may decrease contraceptive effectiveness, requiring additional contraceptive measures. Consult with a healthcare provider about all prescription and over-the-counter medications being taken concurrently.
Missed dose
If one active tablet is missed (24-48 hours late): take it as soon as remembered and take the next tablet at the regular time. No backup contraception is needed. If two active tablets are missed in weeks 1 or 2: take two tablets as soon as remembered and two tablets the next day, then resume regular schedule. Use backup contraception for 7 days. If two active tablets are missed in week 3 or three or more active tablets are missed at any time: follow specific instructions provided with packaging or contact healthcare provider for guidance, as different protocols apply based on where in the cycle the missed doses occurred.
Overdose
Serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives. Overdose may cause nausea, vomiting, and withdrawal bleeding. Treatment should be symptomatic and supportive. There is no specific antidote. Contact a poison control center or healthcare provider for guidance if significant overdose occurs.
Storage
Store at room temperature (20-25°C or 68-77°F) in a dry place protected from light. Keep out of reach of children and pets. Do not use if blister seals are broken or tablets appear damaged. Properly dispose of expired medication according to local guidelines.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult with a qualified healthcare professional before starting, changing, or stopping any medication. The prescribing physician should be aware of the patient’s complete medical history and current health status when considering Mircette therapy.
Reviews
Clinical studies demonstrate Mircette’s efficacy with a Pearl Index of approximately 0.4-1.5 pregnancies per 100 woman-years with perfect use. Patient satisfaction surveys indicate generally favorable experiences regarding cycle control and side effect profile. Many users report appreciation for the lower hormone content compared to standard combination oral contraceptives. Some patients note improved acne and more predictable withdrawal bleeding. As with all hormonal contraceptives, individual experiences vary considerably based on physiological factors and adherence to dosing schedule.